ORYZON to participate in upcoming events in September and October

Partners

Oryzon Genomics will participate in several international investment and capital markets events in the United States and Europe throughout September and October. The biopharmaceutical company will present its activities to investors and hold one-to-one meetings as part of these events.

11 September 2026

Healthcare

Innovative drugs

International

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events:

HC Wainwright 28th Annual Global Investment Conference 2026, September 14-16 Location: Lotte New York Palace Hotel, New York, United States Presentation date and time: September 15, 10:30 am
ET European Main MidCap Event Paris 2026, September 30-October 1 Location: Hotel Four Seasons George V, Paris, France
ODDO BHF Iberian Digital Forum, October 5-6 Location: Virtual
OTC Global Markets Forum, October 7 Location: OTCQX Markets Center, New York, United States Oryzon management will be available for one-on-one meetings during the conferences.

Attached files

20260910 PR upcoming events SEP OCT_ESP.pdf 268.16 KB Download